Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015

Pseudomonas aeruginosa is intrinsically resistant to many antimicrobial drugs, making carbapenems crucial in clinical management. During July–October 2015 in the United States, we piloted laboratory-based surveillance for carbapenem-resistant P. aeruginosa (CRPA) at sentinel facilities in Georgia, N...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Emerging Infectious Diseases
المؤلفون الرئيسيون:	Maroya Spalding Walters, Julian E. Grass, Sandra N. Bulens, Emily B. Hancock, Erin C. Phipps, Daniel Muleta, Jackie Mounsey, Marion A. Kainer, Cathleen Concannon, Ghinwa Dumyati, Chris Bower, Jesse Jacob, P. Maureen Cassidy, Zintars Beldavs, Karissa Culbreath, Walter E. Phillips, Dwight J. Hardy, Roberto L. Vargas, Margret Oethinger, Uzma Ansari, Richard Stanton, Valerie Albrecht, Alison Laufer Halpin, Maria Karlsson, J. Kamile Rasheed, Alexander Kallen
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Centers for Disease Control and Prevention 2019-07-01
الموضوعات:	Pseudomonas aeruginosa carbapenem resistance carbapenemase multidrug-resistant antimicrobial resistance United States
الوصول للمادة أونلاين:	https://wwwnc.cdc.gov/eid/article/25/7/18-1200_article